Piper Sandler Initiates Coverage On Innoviva with Overweight Rating, Announces Price Target of $29
Benzinga Newsdesk 13 hours ago
Analyst RatingsNewsInitiationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Piper Sandler analyst David Amsellem initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $29.
Piper Sandler analyst David Amsellem initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $29.
